Sarcoma patient registry for people treated in France
Part of Cancer clinical trials.
This trial builds a national database of people diagnosed with sarcoma in French cancer centers. It may help researchers better understand sarcoma types and care patterns, which can improve future treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with sarcoma
- Your diagnosis happened at a French comprehensive cancer center
- You can be any age
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information and blood samples from adults with sarcoma who had surgery and possibly radiation. The goal is to build a large dataset that helps researchers understand sarcoma better and improve future care.
This trial is a health registry that collects information about people with soft-tissue or bone sarcoma. It helps researchers understand how the disease behaves and what outcomes different treatments lead to.
This study is a German “registry,” meaning it collects information about people with specific bone or soft tissue tumors (including some borderline or hard-to-classify cases). It helps doctors and researchers learn more about these rare conditions to improve future care.
This study collects tissue samples and medical data from people with sarcoma who are receiving or will receive immunotherapy. Its goal is to learn more about how these treatments work against sarcoma.
This trial tests a combination of a PARP inhibitor drug, targeted radiation (SBRT), and immunotherapy for people with advanced sarcoma that has spread. It aims to see if this triple therapy can shrink tumors or slow the disease.
This study collects information from children and young adults who are getting radiation therapy to help improve future treatments. It looks at how radiation affects the body over time.
Hear when a new Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.